Literature DB >> 3956894

Risk factors for the development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitus.

B Weber, W Burger, R Hartmann, G Hövener, R Malchus, U Oberdisse.   

Abstract

In our preceding paper, the prevalence and development of retinopathy in 231 Type 1 diabetic children and adolescents were reported to be associated with the duration of diabetes and its age at onset. This paper analyses the relationships between the development of retinopathy and the following factors: age, sex, puberty, blood pressure, insulin dosage, HLA antigens, long-term glycaemic control, and serum cholesterol and triglycerides. All these variables were longitudinally evaluated in a cohort of 322 insulin-dependent patients aged 16.2 +/- 4.9 years with diabetes for 7.4 +/- 5.2 years, including those 231 subjects whose eyes were examined once or repeatedly by ophthalmoscopy and fluorescein angiography. Long-term glycaemic control from the onset of diabetes to the retinal examination was assessed by both an arbitrary score comprising different parameters and by mean values of glycosylated haemoglobin, and was categorised as good, fair, and poor. With life-table analysis, the overall median individual risk for developing early retinal changes (9.1 years) was found to be significantly influenced by glycaemic control. Minimal lesions developed earlier (8.0 years) with poor control, but later with fair (10.5 years) and good glycaemic control (12.5 years) (p less than 0.01). Mean HbA1 values below 10% delayed the onset of both incipient (10.8 years) and background retinopathy (16.6 years), while values above 10% advanced it (8.0 and 11.8 years respectively) (p less than 0.05 and less than 0.008). By multivariate regression and stepwise discrimination analyses, only 4 out of 14 variables were found to exert significant independent influences on the development of retinopathy: diabetes duration, long-term glycaemic control, serum triglycerides and age.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3956894     DOI: 10.1007/bf02427276

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

1.  Changes in serum proteins, lipoproteins, and protein-bound carbohydrates in relation to pathologic alterations in the microcirculation of diabetic subjects.

Authors:  J DITZEL; P MOINAT
Journal:  J Lab Clin Med       Date:  1959-12

2.  Serum lipids and polysaccharides in diabetes mellitus.

Authors:  D ADLERSBERG; C I WANG; H RIFKIN; J BERKMAN; G ROSS; C WEINSTEIN
Journal:  Diabetes       Date:  1956 Mar-Apr       Impact factor: 9.461

3.  Serum lipoproteins and cholesterol levels in normal subjects and in young patients with diabetes in relation to vascular complications.

Authors:  N R KEIDING; G V MANN; H F ROOT; E Y LAWRY; A MARBLE
Journal:  Diabetes       Date:  1952 Nov-Dec       Impact factor: 9.461

4.  [Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (author's transl)].

Authors:  J Pirart
Journal:  Diabete Metab       Date:  1977-06

5.  [Control of diabetes and prevention of complications].

Authors:  G R Constam
Journal:  Journ Annu Diabetol Hotel Dieu       Date:  1972

6.  Genetic contribution to retinopathy.

Authors:  J Barbosa; R Ramsay
Journal:  Diabetologia       Date:  1980-06       Impact factor: 10.122

7.  Low density lipoprotein cholesterol: an association with the severity of diabetic retinopathy.

Authors:  T L Dornan; R D Carter; A J Bron; R C Turner; J I Mann
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

8.  Retinopathy in juvenile-onset type I diabetes of short duration.

Authors:  R N Frank; W H Hoffman; M J Podgor; H C Joondeph; R A Lewis; R R Margherio; D P Nachazel; H Weiss; K W Christopherson; M A Cronin
Journal:  Diabetes       Date:  1982-10       Impact factor: 9.461

9.  Plasma-lipids and glucose/insulin relationship in non-insulin-requiring diabetics with and without retinopathy.

Authors:  A H Kissebah; E M Kohner; B Lewis; Y K Siddiq; C Lowy; T R Fraser
Journal:  Lancet       Date:  1975-05-17       Impact factor: 79.321

Review 10.  Lipid disorders in diabetes.

Authors:  R B Goldberg
Journal:  Diabetes Care       Date:  1981 Sep-Oct       Impact factor: 19.112

View more
  26 in total

1.  Indwelling cannula for insulin administration in diabetes mellitus.

Authors:  A M Long; I A Hughes
Journal:  Arch Dis Child       Date:  1991-03       Impact factor: 3.791

2.  Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Jensen; T Lauritzen; T Deckert
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

Review 3.  Can retinopathy be prevented?

Authors:  B Weber; G Hövener; W Burger; R Hartmann; I Enders
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

Review 4.  Diabetic control and microvascular complications: the near-normoglycaemic experience.

Authors:  K F Hanssen; K Dahl-Jørgensen; T Lauritzen; B Feldt-Rasmussen; O Brinchmann-Hansen; T Deckert
Journal:  Diabetologia       Date:  1986-10       Impact factor: 10.122

5.  Clinical and metabolic factors associated with the blood retinal barrier permeability in insulin dependent diabetes mellitus without retinopathy.

Authors:  J M Benitez del Castillo; A Castillo; P C Fernandez; J Garcia Sanchez
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

6.  Prevalence and risk factors for diabetic retinopathy among Omani diabetics.

Authors:  O A el Haddad; M K Saad
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

7.  Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats.

Authors:  H P Hammes; S S Ali; M Uhlmann; A Weiss; K Federlin; K Geisen; M Brownlee
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

8.  Plasma ultrafiltrable magnesium in insulin dependent diabetics.

Authors:  I R Gunn; E Burns
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

9.  Genetic and metabolic risk factors for the development of late complications in type I (insulin-dependent) diabetes.

Authors:  A E Pontiroli; A Calderara; L Bonisolli; P Maffi; A De Pasqua; A Margonato; G Radaelli; G Gallus; G Pozza
Journal:  Acta Diabetol Lat       Date:  1986 Oct-Dec

10.  Risks of jet injection of insulin in children.

Authors:  G E Theintz; P C Sizonenko
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.